Anti-Tumor Drugs Under Closer Scrutiny As China Confronts Widespread Misuse
Executive Summary
China has introduced new rules relating to the designation and control of cancer drugs, which are being seen by some specialists as not ideal from a clinical practice perspective but positive for novel drug development.